The CRTOH is dedicated to promoting translational and interdisciplinary cancer research that has the potential to quickly benefit patients. Our focus is on advancing the understanding and treatment of cancer through close collaboration between clinicians and basic researchers, working together in a multidisciplinary environment.

Our ongoing research efforts are centered around several key areas, including Tumor Immunology and Immunotherapy, Precision Oncology, Cell Division and Cancer, and Cancer Pharmacology. These areas encompass a wide range of approaches, from exploring the immune system's role in fighting cancer to using detailed tumor  information to guide personalized treatment, and from understanding the  fundamental processes that drive cancer growth to developing more effective drugs.